loadpatents
name:-0.03567099571228
name:-0.014799833297729
name:-0.006505012512207
GANDHI; Anita Patent Filings

GANDHI; Anita

Patent Applications and Registrations

Patent applications and USPTO patent grants for GANDHI; Anita.The latest application filed is for "methods for determining drug efficacy for the treatment of diffuse large b-cell lymphoma, multiple myeloma, and myeloid cancers".

Company Profile
6.14.33
  • GANDHI; Anita - Bernardsville NJ
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Methods For Determining Drug Efficacy For The Treatment Of Diffuse Large B-cell Lymphoma, Multiple Myeloma, And Myeloid Cancers
App 20220003749 - TROTTER; Matthew William Burnell ;   et al.
2022-01-06
Treatment Of Immune-related And Inflammatory Diseases
App 20210340132 - Schafer; Peter H. ;   et al.
2021-11-04
Methods for determining drug efficacy for the treatment of diffuse large B-cell lymphoma, multiple myeloma, and myeloid cancers
Grant 10,996,215 - Trotter , et al. May 4, 2
2021-05-04
Treatment Of Immune-related And Inflammatory Diseases
App 20210122727 - Schafer; Peter H. ;   et al.
2021-04-29
Combination therapy for treatment of hematological cancers and solid tumors
Grant 10,973,822 - Gandhi , et al. April 13, 2
2021-04-13
Methods For Treating Diffuse Large B-cell Lymphoma And The Use Of Biomarkers As A Predictor To Responsiveness To Drugs
App 20210102257 - Trotter; Matthew William Burnell ;   et al.
2021-04-08
Treatment of immune-related and inflammatory diseases
Grant 10,919,883 - Schafer , et al. February 16, 2
2021-02-16
Methods for treating diffuse large B-cell lymphoma and the use of biomarkers as a predictor of responsiveness to drugs
Grant 10,689,708 - Trotter , et al.
2020-06-23
Methods Of Treating Cancer Using 3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,- 6-dione
App 20190388429 - Schafer; Peter H. ;   et al.
2019-12-26
Methods For Determining Drug Efficacy For The Treatment Of Diffuse Large B-cell Lymphoma, Multiple Myeloma, And Myeloid Cancers
App 20190004033 - TROTTER; Matthew William Burnell ;   et al.
2019-01-03
Cycling therapy using 3-(5-amino-2-methyl-4-oxo-4H-quinazolin-3-yl)-piperidine-2,6-dione
Grant 10,159,675 - Hagner , et al. Dec
2018-12-25
Methods For Treating Hematological Cancer And The Use Of Biomarkers As A Predictor For Responsiveness To Treatment Compounds
App 20180238886 - GANDHI; Anita ;   et al.
2018-08-23
Methods For Treating Solid Tumors And The Use Of Biomarkers As A Predictor Of Clinical Sensitivity To Immunomodulatory Therapies
App 20180231561 - GANDHI; Anita ;   et al.
2018-08-16
Methods for the treatment of cancer and inflammatory diseases using cereblon as a predictor
Grant 10,047,151 - Lopez-Girona , et al. August 14, 2
2018-08-14
Combination Therapy For Treatment Of Hematological Cancers And Solid Tumors
App 20180193342 - Gandhi; Anita ;   et al.
2018-07-12
Methods Of Treating Cancer Using 3-(5-amino-2-methyl-4-oxo-4h-quinazolin-3-yl)-piperidine-2,6-dione
App 20180055844 - Muller; George W. ;   et al.
2018-03-01
Cereblon Isoforms And Their Use As Biomarkers For Therapeutic Treatment
App 20170362660 - THAKURTA; Anjan ;   et al.
2017-12-21
Methods For Treating Solid Tumors And The Use Of Biomarkers As A Predictor Of Clinical Sensitivity To Immunomodulatory Therapies
App 20170242014 - HAGNER; Patrick ;   et al.
2017-08-24
Methods for the treatment of locally advanced breast cancer
Grant 9,694,015 - Gandhi , et al. July 4, 2
2017-07-04
Use Of 3-(5-amino-2-methyl-4-oxoquinazolin-3(4h)-yl)piperidine-2,6-dione In Treatment Of Immune-related And Inflammatory Diseases
App 20170165266 - Gandhi; Anita ;   et al.
2017-06-15
Methods Of Treating Diffuse Large B-cell Lymphoma Using 3-(4-amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione
App 20170157103 - Thakurta; Anjan ;   et al.
2017-06-08
Cycling Therapy Using 3-(5-amino-2-methyl-4-oxo-4h-quinazolin-3-yl)-piperidine-2,6-dione
App 20170157123 - Hagner; Patrick ;   et al.
2017-06-08
Combination Therapy For Cancer
App 20170128448 - Pourdehnad; Michael ;   et al.
2017-05-11
Methods For Treating Diffuse Large B-cell Lymphoma And The Use Of Biomarkers As A Predictor Of Responsiveness To Drugs
App 20170088901 - Trotter; Matthew William Burnell ;   et al.
2017-03-30
Cereblon isoforms and their use as biomarkers for therapeutic treatment
Grant 9,587,281 - Thakurta , et al. March 7, 2
2017-03-07
Methods For Treating Chronic Lymphocytic Leukemia And The Use Of Biomarkers As A Predictor Of Clinical Sensitivity To Immunomodulatory Therapies
App 20170038387 - Gandhi; Anita ;   et al.
2017-02-09
Methods For The Treatment Of Cancer And Inflammatory Diseases Using Cereblon As A Predictor
App 20160319005 - Lopez-Girona; Antonia ;   et al.
2016-11-03
Methods For Determining Drug Efficacy For The Treatment Of Diffuse Large B-cell Lymphoma, Multiple Myeloma, And Myeloid Cancers
App 20160313300 - Trotter; Matthew William Burnell ;   et al.
2016-10-27
Methods Of Treating Cancer Using 3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,- 6-dione
App 20160256468 - Schafer; Peter H. ;   et al.
2016-09-08
Methods for the treatment of cancer and inflammatory diseases using cereblon as a predictor
Grant 9,365,640 - Lopez-Girona , et al. June 14, 2
2016-06-14
Use Of 3-(5-amino-2-methyl-4-oxoquinazolin-3(4h)-yl)piperidine-2,6-dione In Treatment Of Immune-related And Inflammatory Diseases
App 20160136167 - Gandhi; Anita ;   et al.
2016-05-19
Methods and compositions using PDE4 inhibitors for the treatment and management of autoimmune and inflammatory diseases
Grant 9,272,035 - Schafer , et al. March 1, 2
2016-03-01
Methods For The Treatment Of Locally Advanced Breast Cancer
App 20150224104 - Gandhi; Anita ;   et al.
2015-08-13
Cereblon Isoforms And Their Use As Biomarkers For Therapeutic Treatment
App 20150152511 - THAKURTA; Anjan ;   et al.
2015-06-04
Methods Of Treating Cancer Using 3-(5-amino-2-methyl-4-oxo-4h-quinazolin-3-yl)-piperidine-2,6-dione
App 20150126538 - MULLER; George W. ;   et al.
2015-05-07
Treatment Of Immune-related And Inflammatory Diseases
App 20150038511 - SCHAFER; PETER H. ;   et al.
2015-02-05
Methods of treating cancer using 3-(5-amino-2-methyl-4-oxo-4Hquinazolin-3-yl)-piperidine-2,6-dione
Grant 8,906,932 - Muller , et al. December 9, 2
2014-12-09
Use Of 3-(5-amino-2-methyl-4-oxoquinazolin-3(4h)-yl)piperidine-2,6-dione In Treatment Of Immune-related And Inflammatory Diseases
App 20140148473 - Gandhi; Anita ;   et al.
2014-05-29
Methods Of Treating Cancer Using 3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,- 6-dione
App 20140045843 - Schafer; Peter H. ;   et al.
2014-02-13
Treatment Of Immune-related And Inflammatory Diseases
App 20140045844 - Schafer; Peter H. ;   et al.
2014-02-13
Methods For The Treatment Of Cancer And Inflammatory Diseases Using Cereblon As A Predictor
App 20120322073 - Lopez-Girona; Antonia ;   et al.
2012-12-20
Methods And Compositions Using Pde4 Inhibitors For The Treatment And Management Of Autoimmune And Inflammatory Diseases
App 20120276087 - SCHAFER; Peter H. ;   et al.
2012-11-01
Methods Of Treating Cancer Using 3-(5-amino-2-methyl-4-oxo-4h-quinazolin-3-yl)-piperidine-2,6-dione
App 20120230983 - Muller; George W. ;   et al.
2012-09-13

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed